The antiapoptotic effect of guanosine is mediated by the activation of the PI 3‐kinase/AKT/PKB pathway in cultured rat astrocytes

GLIA - Tập 46 Số 4 - Trang 356-368 - 2004
Patrizia Di Iorio1, Patrizia Ballerini1, U. Traversa2, Ferdinando Nicoletti3, Iolanda D’Alimonte1, Sonya Kleywegt1,4, Eva S. Werstiuk4, Michel P. Rathbone4, Francesco Caciagli1, Renata Ciccarelli1
1Department of Biomedical Sciences, School of Medicine, University of Chieti, Chieti, Italy
2Department of Biomedical Sciences, School of Pharmacy, University of Trieste, Trieste, Italy
3Department of Physiology and Pharmacology, School of Medicine, University of Roma "La Sapienza," Rome, Italy
4Department of Medicine, McMaster University Health Sciences Centre, Hamilton, Ontario, Canada.

Tóm tắt

AbstractGuanosine has many trophic effects in the CNS, including the stimulation of neurotrophic factor synthesis and release by astrocytes, which protect neurons against excitotoxic death. Therefore, we questioned whether guanosine protected astrocytes against apoptosis induced by staurosporine. We evaluated apoptosis in cultured rat brain astrocytes, following exposure (3 h) to 100 nM staurosporine by acridine orange staining or by oligonucleosome, or caspase‐3 ELISA assays. Staurosporine promoted apoptosis rapidly, reaching its maximal effect (∼ 10‐fold over basal apoptotic values) in 18–24 h after its administration to astrocytes. Guanosine, added to the culture medium for 4 h, starting from 1 h prior to staurosporine, reduced the proportion of apoptotic cells in a concentration‐dependent manner. The IC50 value for the inhibitory effect of guanosine is 7.5 × 10−5 M. The protective effect of guanosine was not affected by inhibiting the nucleoside transporters by propentophylline, or by the selective antagonists of the adenosine A1 or A2 receptors (DPCPX or DMPX), or by an antagonist of the P2X and P2Y purine receptors (suramin). In contrast, pretreatment of astrocytes with pertussis toxin, which uncouples Gi‐proteins from their receptors, abolished the antiapoptotic effect of guanosine. The protective effect of guanosine was also reduced by pretreatment of astrocytes with inhibitors of the phosphoinositide 3‐kinase (PI3K; LY294002, 30 μM) or the MAPK pathway (PD98059, 10 μM). Addition of guanosine caused a rapid phosphorylation of Akt/PKB, and glycogen synthase kinase‐3β (GSK‐3β) and induced an upregulation of Bcl‐2 mRNA and protein expression. These data demonstrate that guanosine protects astrocytes against staurosporine‐induced apoptosis by activating multiple pathways, and these are mediated by a Gi‐protein‐coupled putative guanosine receptor. © 2004 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1006/bbrc.1995.2215

10.1111/j.1749-6632.1997.tb48410.x

10.1126/science.281.5381.1322

10.1016/S0006-8993(02)02365-X

10.1073/pnas.94.8.3627

10.1046/j.1471-4159.2002.01015.x

10.1038/sj.onc.1204436

10.1128/MCB.17.8.4346

Berra E, 1998, The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3‐kinase/Akt pathway, J Biochem, 273, 10792

10.1016/S0968-0004(01)01958-2

10.1016/0003-2697(76)90527-3

10.1016/S0092-8674(00)80595-4

Caciagli F, 2000, The neuroprotective activity of guanosine involves the production of trophic factors and the outflow of purines from astrocytes, Drug Dev Res Abstract, 50, 32

10.1126/science.296.5573.1655

10.1126/science.282.5392.1318

10.1002/(SICI)1097-4547(19970215)47:4<372::AID-JNR2>3.0.CO;2-B

10.1111/j.1471-4159.2007.04586.x

10.1038/nrn1078

10.1002/(SICI)1098-1136(19990101)25:1<93::AID-GLIA9>3.0.CO;2-N

10.1002/(SICI)1098-1136(20000201)29:3<202::AID-GLIA2>3.0.CO;2-C

10.1016/S0304-3940(00)01207-6

10.1007/BF02736783

10.1038/378785a0

10.1016/S0092-8674(00)80405-5

Dawicki DD, 1997, Extracellular ATP and adenosine cause apoptosis of pulmonary artery endothelial cells, Am J Physiol, 273, L485

10.1016/S0165-0173(00)00033-3

10.1038/sj.cdd.4400641

10.1002/ddr.1128

10.1002/glia.10055

10.1016/S0955-0674(98)80149-X

10.1111/j.1471-4159.2006.04249.x

10.1126/science.275.5300.665

10.1016/S0092-8674(00)81883-8

10.1097/00001756-200103260-00051

10.1146/annurev.biochem.67.1.481

10.1523/JNEUROSCI.06-08-02163.1986

10.1074/jbc.M205797200

10.1016/S0092-8674(00)81728-6

10.1038/35037710

10.1523/JNEUROSCI.20-07-02567.2000

10.1074/jbc.C100174200

10.1101/gad.11.6.701

10.1002/path.1711050103

10.1128/MCB.21.3.893-901.2001

10.1002/jnr.490280318

10.1046/j.1365-2990.2002.00390.x

10.1523/JNEUROSCI.18-20-08186.1998

10.1523/JNEUROSCI.19-17-07394.1999

10.1002/(SICI)1097-4547(19980201)51:3<293::AID-JNR3>3.0.CO;2-B

10.1074/jbc.272.33.20490

10.1111/j.1471-4159.1991.tb08220.x

10.1046/j.1471-4159.1998.70010130.x

10.1038/35040009

10.1016/0006-8993(95)00156-K

10.1002/1096-9926(200007)62:1<14::AID-TERA6>3.0.CO;2-9

10.1074/jbc.273.30.19080

10.1083/jcb.200101068

10.1074/jbc.273.32.19929

10.1016/0006-2952(93)90499-M

10.1007/BF02634137

10.1097/00002093-199803001-00006

10.1038/43474

10.1152/ajplung.1998.275.2.L379

10.1023/A:1006891430596

10.1126/science.7878463

10.1042/bj3040877

10.1126/science.281.5381.1312

10.1038/sj.bjp.0704542

Traversa U, 2002, Identification of a guanosine receptor linked to the modulation of adenylate cyclase and MAPK activity in primary cultures of rat astrocytes, 9

10.1161/01.STR.22.12.1548

10.1042/0264-6021:3460561

10.1016/S0021-9258(17)37680-9

10.1113/jphysiol.1995.sp020951

10.1007/s004010050906

10.1046/j.1471-4159.1996.66041418.x

10.1016/S0165-6147(03)00163-9

10.1126/science.270.5240.1326

10.1126/science.7701324

10.1038/35037739

10.1016/0304-3940(82)90338-X